Shree Ganesh Biotech (India) share news, announcements and annual reports
BSE: 539470Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 29 Oct 2026. Previous close ₹0.44.
29 Oct: open ₹0.45, high ₹0.47, low ₹0.44
- Next results date: the board meets on 2 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹19 Cr3,998th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.29
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 5,24,209
Shree Ganesh Biotech (India) has 460 announcements on record, routine notices left out; 2 in the 30 days to 30 Oct 2026, the latest on 23 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Shree Ganesh Biotech (India) quarterly results
The board meets on 2 Nov 2026 to consider quarterly results
Notice filed 23 Oct 2026
Shree Ganesh Biotech (India) annual reports, presentations and earnings calls
The company's own documents, latest first.Shree Ganesh Biotech (India) financials, year by year
Annual reports15
- Annual report, year to Mar 20263 Sep 2026
- Annual report, year to Mar 202525 Aug 2025
- Annual report, year to Mar 20244 Sep 2024
- Annual report, year to Mar 20231 Sep 2023
- Annual report, year to Mar 20225 Sep 2022
10 earlier reports
- Annual report, year to Mar 202126 Aug 2021
- Annual report, year to Mar 202029 Aug 2020
- Annual report, year to Mar 201929 Aug 2019
- Annual report, year to Mar 20186 Oct 2018
- Annual report, year to Mar 201715 Sep 2017
- Annual report, year to Mar 20166 Oct 2016
- Annual report, year to Mar 2015Filing day not known
- Annual report, year to Mar 2014Filing day not known
- Annual report, year to Mar 2013Filing day not known
- Annual report, year to Mar 2012Filing day not known
Shree Ganesh Biotech (India) share news and announcements
Newest first. Page 1 of 10.
Oct 2026
23 Oct · Board meeting
Meeting on 2 Nov 2026: quarterly results
Sep 2026
28 Sep · Meeting
28 Sep · Meeting
Aug 2026
Jul 2026
21 Jul · Board meeting
Meeting on 4 Aug 2026: quarterly results
May 2026
4 May · Board meeting
Meeting on 14 May 2026: audited results
Jan 2026
19 Jan · Board meeting
Meeting on 29 Jan 2026: quarterly results
Nov 2025
Oct 2025
30 Oct · Board meeting
Meeting on 8 Nov 2025: quarterly results
Sep 2025
26 Sep · Meeting
26 Sep · Meeting
Aug 2025
Jul 2025
16 Jul · Board meeting
Meeting on 25 Jul 2025: quarterly results
May 2025
12 May · Board meeting
Meeting on 22 May 2025: audited results
Feb 2025
4 Feb · Results
Jan 2025
20 Jan · Board meeting
Meeting on 4 Feb 2025: quarterly results
Oct 2024
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 12 Sep 2023Board or managers changeddown 3.06%−2.0 pts vs Nifty 500market median 0.0% · five sessions −7.1% (−6.9 pts vs Nifty 500) · volume 2.3× usual · The announcement
- 30 Jun 2023Board or managers changeddown 0.92%−1.9 pts vs Nifty 500market median 0.0% · five sessions −1.8% (−4.4 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 17 Mar 2020Board or managers changed–market median 0.0% · volume 0.1× usual · The announcement